Orchestra BioMed Holdings, Inc. Ordinary Shares (OBIO) is a publicly traded Healthcare sector company. As of May 21, 2026, OBIO trades at $3.91 with a market cap of $238.33M and a P/E ratio of -3.57. OBIO moved +0.13% today. Year to date, OBIO is -6.13%; over the trailing twelve months it is +34.92%. Its 52-week range spans $2.20 to $6.50. Analyst consensus is strong buy with an average price target of $13.40. Rallies surfaces OBIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Orchestra BioMed Holdings, Inc. Ordinary Shares (OBIO) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. OBIO moved +0.13% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $3.91 |
| Market Cap | $238.33M |
| P/E Ratio | -3.57 |
| EPS | $-1.11 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.50 |
| 52-Week Low | $2.20 |
| Volume | 85.23K |
| Avg Volume | 0 |
| Revenue (TTM) | $33.48M |
| Net Income | $-52.70M |
| Gross Margin | 99.43% |
6 analysts cover OBIO: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $13.40.